FUROSCIX (NDA209988)- (80MG/10ML (8MG/ML))

Generic Name	FUROSEMIDE	Innovator	SCPHARMACEUTICALS
Dosage	80MG/10ML (8MG/ML)
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	2034-Apr-03	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2025-Oct-07
GAIN Expiry	None	Drug Complexity	No
Indication	FUROSCIX is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
80MG/10ML (8MG/ML)	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of FUROSCIX